Suzhou Basecare Medical Corporation Limited (HKG:2170)

Hong Kong · Delayed Price · Currency is HKD

1.265

+0.025 (2.02%)

Oct 2, 2026, 1:17 PM HKT

Market Cap	346.01M -58.4%
Revenue (ttm)	300.95M -5.5%
Net Income	-200.91M
EPS	-0.73
Shares Out	273.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,000
Open	1.230
Previous Close	1.240
Day's Range	1.230 - 1.265
52-Week Range	1.200 - 3.210
Beta	0.04
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About HKG:2170

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People’s Republic of China and Australia. The company offers pre-implantation genetic test kits, including PGT-A kit to detect aneuploidy; PGT-M kit to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kit to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage, implantation failures, and birth defects. It also provides DA500, a... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2010

Employees 388

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2170

Full Company Profile

Financial Performance

In 2025, HKG:2170's revenue was 233.27 million, a decrease of -22.01% compared to the previous year's 299.11 million. Losses were -223.46 million, -5.73% less than in 2024.

Financial numbers in CNY Financial Statements